More Articles

Commercial

Patenting the human genome

Editor, (May 17, 2001)

BUSINESS IN THE POST GENOMICS ERA: CHAIRED BY: Dr Romeo Paioni, Head Scientific and External Affairs, Novartis Pharma

Keynote: A big pharma research platform, for all our partners

Editor, (May 17, 2001)

Wolf-Dieter Busse, SVP, Head of Biotechnology R&D, Bayer Corporation Keynote: A big Pharma research platform, for all our partners

Keynote: 21st Century procurement the GlaxoSmithKline way

Editor, (May 17, 2001)

Keynote: 21st Century procurement the GlaxoSmithKline way Willie Deese, SVP Global Procurement, GlaxoSmithKline
Commercial

Executive Case Study: Proteomics - the next quest in the post genomics era

Editor, (May 17, 2001)

BUSINESS IN THE POST GENOMICS ERA: CHAIRED BY: Dr Romeo Paioni, Head Scientific and External Affairs, Novartis Pharma

4SC and PACT complete virtual HTP drug screening pilot

Editor, (May 17, 2001)

Through a combination of 4SC's proprietary virtual-high-throughput technology and PACT's XPU microprocessor technology, the alliance contends it has been able to increase the speed of computer

Agilent and Merck to continue gene expression analysis solutions alliance

Editor, (May 17, 2001)

On May 11, Merck and Rosetta announced an agreement under which Merck will acquire Rosetta.

Pages